The synthesis of a range of dl-and triester derivatives of phosphonoformate (PFA; foscarnet) as potential lipophilic, membrane-soluble prodrugs is described. In addition to normal alkyl esters in the carboxylate and phosphonate residues of PFA, the bioreversible S-(pivaloyl)thioethyl (t-butyl-SATE) group was introduced in an attempt to deliver PFA after bioactivation inside the cells. Furthermore, PFA-AZT conjugates were prepared in order to develop combinational drugs. The key synthetic step was in all cases the formation of the P-C bond to build up the different PFA esters. In contrast to the diester derivatives, the triesters of PFA showed high hydrolytic instability during chromatographic purification. The compounds
Introduction
The development of reverse transcriptase inhibitors is one approach to AIDS chemotherapy (Mitsuya & Broder, 1987; De Clercq, 1995) . In this regard, several compounds based on the nucleoside analogue concept have been developed (Herdewijn et al., 1993 ). An example is the nucleoside analogue 3' -azido-2',3' -dideoxythymidine (AZT; zidovudine; 2, Fig. 1 ), which was the first drug approved for the clinical treatment of AIDS and AIDSrelated complex (ARC). Non-nucleoside reverse transcriptase inhibitors have also been developed. An example of this group is phosphonoformic acid (PFA; foscarnet; foscarvir; normally available as its trisodium salt, 1, Fig. 1 ), which is currently used to treat patients with human cytomegalovirus (HCMV) infections (Oberg, 1983; Wagstaff & Bryson, 1994; Gerard & Salmon-Ceron, 1995) and which was also reported to possess anti- ©1998 International Medical Press 0956-3202/98/$17.00 were evaluated in vitro for their ability to inhibit viruses in several tissue culture systems. All PFA alkyl di-and triesters proved poorly active or inactive against human immunodeficiency virus (HIV) and inactive against hepatitis B virus. In contrast, the PFA-AZT conjugates exhibited significant anti-HIV activity. However, this activity was nearly completely lost in thymidine kinase-deficient cells, suggesting a fast unselective chemical hydrolysis of the conjugates to yield the nucleoside analogue AZT in the cell culture medium. Furthermore, no synergistic effect of PFA and AZT was observed.
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hepatitis B VIruS (HBV) activity III animal models (Sherker et al., 1986) .
The biological mode of action ofAZT (2) is the inhibition of reverse transcriptase and/or its ability to act as a chain elongation terminator, but the intracellular conversion ofAZT into its 5' -triphosphate by cellular kinases is a prerequisite for the expression of this biological activity (Furman et al., 1986; Balzarini et al., 1989) . In contrast, PFA (1) acts as a pyrophosphate analogue without further metabolization and inhibits the reverse transcriptase of human immunodeficiency virus (HIV) (Fletcher et al., 1994) , as well as herpes simplex virus (HSV) (Li et al., 1995) and HCMV DNA polymerases (Chrisp & Clissold, 1991) . Additionally, PFA is a selective inhibitor of the reverse transcriptase with respect to human DNA polymerases. Unfortunately, owing to its high polarity, PFA Figure 1 . Structure of the parent antiviral drugs PFA (1) and AZT (2), and general structure of mono-, di-and tri-ester derivatives of PFA. Triester derivatives of PFA shows poor penetration into cells and is not available in a formulation for oral administration. For these reasons, it must be administered intravenously and in high doses (200 mg/kg/day) (Wagstaff & Bryson, 1994) . Hence, an orally available prodrug of PFA would be highly desirable. As a consequence, increased ease of administration and lower doses would be possible. With respect to this aim, several lipophilic mono-, di-and triester prodrugs ofPFA ( Fig. 1 ) have been synthesized previously (Noren et al., 1983; Vaghefi et al., 1986; Griengl et al, 1988; Lambert et al., 1989; Iyer et al., 1989 Iyer et al., , 1994 Neto et al., 1990; Rosowsky et al., 1990; Saha et al., 1991; Charvet et al, 1994; Walker et al., 1994; Hostetler et al, 1996; Briggs et al, 1996) . One of the major limitations ofthis approach is the high instability towards chemical hydrolysis of simple alkyl or aryl PFA triester prodrugs, which leads primarily to a P-C bond scission at physiological pH (Krol et al, 1991; Krol & Thatcher, 1993; Mitchell et al, 1991 Mitchell et al, , 1992 . In contrast to the PFA triesters, PFA-AZT diester (Rosowsky et al, 1990 (Rosowsky et al, , 1997 Saha et al, 1991) as well as PFA-pivaloyloxymethyl (PaM) diesters (Iyer et al., 1989 (Iyer et al., , 1994 Briggs et al, 1996) have been reported to be of potential therapeutic value in antiviral chemotherapy. Here, we report the synthesis and in vitro biological evaluation of hitherto unknown PFA di-and triesters 3-6 (Fig.  2 ) bearing alkyl ester residues as well as the biolabile ester protecting group S-pivaloyl-2-thioethyl (t-butyl-SATE) as potential HIV and HBV active agents. A biolabile S-acyl-2-thioethyl (SATE) group, which has been used successfully in the pronucleotide approach for kinase bypass before (Gosselin & Imbach, 1993; Perigaud et al, 1993 Perigaud et al, , 1994 Perigaud et al, , 1996 Girardet et al., 1995; Lefebvre et al., 1995) was 42 chosen because we reasoned that, owing to the high carboxyesterase concentration inside the cell, a fast and selective intracellular de-esterification of the SATE-di-or triester derivatives by carboxyesterases would lead to charged compounds that are protected against unselective chemical hydrolysis and at the same time are locked inside the cells. The tert-butyl derivative was chosen because this ester was the most promising candidate as judged from earlier studies (Benzaria et al., 1996; Valette et al., 1996; Perigaud et al., 1997) . The PFA diesters were studied because we believed that the polarity of these compounds, owing to the remaining charge at the phosphonate moiety, could be compensated by highly lipophilic esters such as the n-octyl as well as the t-butyl-SATE groups. The advantage of the diesters is clearly their higher stability towards unselective chemical hydrolysis as compared to the triesters. The rationale for the PFA-AZT conjugates (7-10; Fig. 2 ) was the previously reported synergistic anti-HIV effect of PFA and AZT when used in combination (Eriksson & Schinazi, 1989; Koshida et al, 1989; Kong et al., 1991; Palmer et al, 1996) . As a consequence, these conjugates could be able to deliver one equivalent of each antivirally active drug.
Materials and Methods: Chemistry
Compounds NMR spectra were recorded using Bruker AM 250/Aspect ';:: II I I~~~J The spectra were recorded at room temperature. Electrospray mass spectra were measured on an mass spectrometer (Fisons VG platform II), The FAB mass spectra were measured on a Jeol DX 300 sector instrument (Tokyo, Japan) in 3-nitrobenzylalcohol as matrix. The elemental analyses were performed using a Foss Heraeus CHN-ORapid. In most cases the elemental analysis gave poor results, which can be attributed to the high hydrolytic lability of the di-TMS ester 13, dichlorides 14, and of the triesters 4-6, 9 and 10, whereas the salts of the diesters 3, 7, 8 ofPFA are hygroscopic. All UV spectra were recorded on a Varian Cary UV spectrometer, IR spectra were recorded on a Perkin-Elmer 1600 Series FTIR spectrometer. Merck precoated plates 60 F254 with a 0.2 mm layer of silica gel were used for thin layer chromatography (TLC 
Bis(trimethylsilyl) 2-(S-pivaloylthio)ethoxycarbonylphosphonate (13b)
The reaction was carried out analogously to that described for 13a. Qpantities: 2-(S-pivaloylthio)ethyl chloroformate l2b (2.5 g, 11.13 mmol), tris (trimethylsilyl) 
The reaction was carried out analogously to that described for 13a. Qpantities: ethyl chloroformate l2e (1.0 g, 9.21 mmol), tris(trimethylsilyl)phosphite (3.02 g, 10.13 mmol). NMR showed a clean reaction to the target compound 13e (colourless oil, 2.47 g, 90% (Iyer et a!., 1989) .
Bis( trimethylsilyl) n-octyloxycarbonylphosphonate 13a (2.58 g, 6.745 mmol) was dissolved in 10 ml CHzCl z in a predried, argon-filled flask. To the stirred solution, 40 ul DMF was added at room temperature and subsequently oxalylchloride (2.56 g, 20.23 mmol) was added dropwise very slowly within 30 min. To complete the reaction, stirring was continued for 1 h. The volatile side products were removed under reduced pressure. The residue was subjected to a Kugelrohr distillation to give 14a as a slight yellow oil (1.58 g, 85% (Vaghefi et al., 1986; Charvet etal., 1994) .
AZT (2) (100 mg, 0.374 mmol) and triethylamine (37 mg, 0.374 mmol, 50 ul) were dissolved in 3 ml acetonitrile at OT. To this solution, n-octyloxycarbonylphosphonic acid dichloride 14a (102 mg, 0.374 mmol) was added as a solution in 1 ml acetonitrile. The solution was stirred for 24 h at room temperature, after which TLC showed complete conversion of the starting material AZT. Subsequently, 200 ul of water in 200~l of methanol was added. After 1 h, the solvent was evaporated under reduced pressure and the residue was purified by silica gel chromatography on a chromatotron using a gradient of CH 2Cl2 and methanol (up to 8:2, starting with 100% CH 2Cl2 ) . To the eluent, 0.2% acetic acid was added in order to stabilize the reaction products. After evaporation of the solvent, compound 7 was isolated as a colourless glass. It was redissolved in water and passed through a cation exchange resin column (Dowex 50-X8, 20~50 mesh, sodium form). The column was eluted with water and the filtrate was concentrated by lyophilization to give the sodium salt of 7 as a colourless 
Bis(4-chlorobenzyl) n-octyloxycarbonylphosphonate (5)
The reaction was carried out analogously to that described for 4. Quantities: n-octyloxycarbonyl-phosphonic acid dichloride 14a (700 mg, 2.55 mmol) , 4-chlorobenzylalcohol (730 mg, 5.10 mmol), triethylamine (515 mg, 5.10 mmol, 708 ul), 6 ml CH 2C12. After chromatography, triester 5 was isolated as a calourless oil (675 mg, 55%) (it should be stressed that the addition of 0.2% acetic acid to the eluent during the chromatotron chromatography was essential for the successful isolation of the triester 5); Rr: 0.45 (CH 2Cl2), Rr: 0.9 (CH 2Cl2-methanol 9.5:0.5); b.p. Bis(5'-[3'-azido-2',3'-dideoxythym id inylD noctyloxycarbonylphosphonate (9)
The reaction was carried out analogously to that described for 4, except that acetonitrile was used as solvent instead of CH 2Cl2. Qpantities: n-octyloxycarbonylphosphonic acid dichloride 14a (154 mg, 0.561 mmol) , 3'-azido-2',3'-dideoxythymidine 2 (300 mg, 1.12 mmol), triethylamine (113 mg, 1.12 mmol, 152 ul), 3 m1 CH 3CN. After chromatography the triester 9 was isolated as a colourless oil (285 mg, 69%) (it should be stressed that the addition of 0.2% acetic acid to the eluent during the chromatotron chromatography was essential for the successful isolation of the triester 9); R, 0.45 (CH 2Ckmethanol 9.5:0.5), Rr: 
The reaction was carried out analogously to that described for 4, except that acetonitrile was used as solvent instead of CH 2Cl2. Quantities: 2-(S-pivaloylthio)ethoxycarbonylphosphonic acid dichloride 14b (114 mg, 0.374 mmol), 3'-azido-2',3'-dideoxythymidine 2 (213 mg, 0.8 mmol), triethylamine (81 mg, 0.8 mmol, 109 ul), 3 ml CH 3CN. After chromatography the triester 10 was isolated as a colourless glass (196 mg, 68%) (it should be stressed that the addition of 0.2% acetic acid to the eluent during the chromatotron chromatography was essential for the successful isolation of the triester 10); R; 0.35 (CH 2Cl2-methanol 9.5:0.5), R, 0.8 (CH 2Cl2-methanol 9:1); m.p. 
Materials and Methods: Virology

Anti-HIVevaluation
The origin of the viruses and the techniques used for measuring inhibition of virus multiplication have previously been described (Puech et al., 1993; Lefebvre et al., 1995) . Briefly, in MT-4 cells, the determination of the antiviral activity of compounds 1-10 was based on a reduction of HIV-1 IIIB-induced cytopathogenicity, the metabolic activity ofthe cells being measured by the property of mitochondrial dehydrogenases to reduce MTT into formazan (Puech et al., 1993; Pauwels et al., 1988; Moog et al., 1994) . For CEM-SS and CEM-TK-cells, the production of virus HIV-lLA! was measured by quantification of the reverse transcriptase activity associated with the virus particle released into the culture supernatant (Puech et al., 1993; Moog et al., 1994) . MT-4 and CEM cells were incubated with 50 and 100 TCID so of virus, respectively, for 30 min; after virus adsorption, unbound particles were eliminated by two washes, and Antiviral Chemistry & Chemotherapy 9:1 Foscarnet esters as potential antiviral prodrugs cells were cultured in the presence of different concentrations of test compounds for 5 days (MT-4 and CEM-SS cells), or 6 days (CEMlTK-cells), before determination of virus production. The 50% effective concentration (EC so ) was derived from the computer-generated median effect plot of the dose-effect data (Chou & Chou, 1985) . In pa-rallel experiments, cytotoxicity of the test compounds was measured after incubation of uninfected cells for 5 days in their presence using the colorimetric MTT test (Mosmann, 1983) . The 50% cytotoxic concentration (CC so ) is the concentration at which A S40 was reduced by one-half and was calculated using the program mentioned above.
Anti-HBVevaluation
The 2.2.15 cells (HBV DNA-transfected human hepatoblastoma-derived HepG2 cells) were cultured as described previously (Korba & Guerin, 1992) and inhibition ofHBV extracellular DNA (HBV virion) or HBV intracellular DNA (HBV replicative intermediate) was determined with minor modifications (El Alaoui et al., 1996) . Cytotoxicity assays were conducted in HepG2 cells, which were maintained in MEM supplemented with 10% heat-inactivated fetal bovine serum, 1% sodium pyruvate and 1% penicillin/streptomycin. Each compound was tested in four concentrations in triplicate cultures and the median inhibitory concentration (IC so ) was determined as previously described (Schinazi et al., 1994) .
Other antiviral evaluations
The broad antiviral assays on cell culture against HCMV, HSV-l, vaccina virus and coxsackie virus B4 were performed by previously established procedures (GenuDellac et al., 1991a,b) .
Results
In principle, two different approaches are possible to yield the PFA di-and triester derivatives 3-10. The first approach starts directly from trisodium phosphonoformate 1 using different esterification procedures (Lambert et al., 1989) . Attempts to synthesize the title compounds 3-10 following this approach were not successful owing to the very low solubility of the starting material 1 in organic solvents. The alternative approach is the formation of the P-C bond of the phosphonoformate structure by the reaction of a chloroformate with silyl phosphites. We decided to use the latter synthetic approach because this allows the introduction of two different ester groups in the PFA diand triester derivatives 3-10. Another advantage of the second method is the use of reactive phosphorus (III) chemistry.The formation of the P-C bond was carried out by reacting different alkyl chloroformates (12) with tris(trimethylsilyl)phosphite in an Arbusov type reaction (Sekine & Hata, 1978; Sekine et al., 1981; Iyer et al., 1989 Iyer et al., , 1994 Vaghefi et al., 1986; Charvet et al., 1994) . In contrast to tris(trimethylsilyl)phosphite and ethyl chloroformate 12c, the chloroformates 12a and 12b are not commercialy available. The n-octyl (12a) as well as the 2-(S-pivaloylthio)ethyl chloroformates 12b were synthesized from the corresponding alcohols lIa and lIb and triphosgene (as a substitute for phosgen) in the presence of the base pyridine (Eckert & Forster, 1987) . Itshould be stressed that only 0.33 equivalents of pyridine with respect to the alcohol were necessary to yield the appropriate chloroformates 12a and b in a clean reaction. The addition of one equivalent of pyridine led to a mixture of the chloroformates, the carbonate diesters and symmetric ethers of the alcohols, respectively. Moreover, the reaction was not successful without addition of pyridine. The products of the Arbusov reaction, the bis(trimethylsilyl)alkoxycarbonylphosphonates 13a-c were subsequently converted into the alkoxycarbonylphosphonic dichlorides 14a-c by reaction with oxalylchloride in the presence of catalytic amounts of DMF (Morita et al., 1980; Bhongle et al., 1987) . The syntheses of the title compounds 3-10 were achieved by esterification of these dichloride intermediates 14a-c with different alcohols such as 2-(Spivaloylthio)ethanol (t-butyl-SATE, I lb) as well as AZT 2 (Walker et al., 1994) . In the case of the synthesis ofPFA diester derivatives 3, 7 and 8, the dichlorides 14 were reacted only with one equivalent of the alcohols, and the phosphonic acid chloride monoester was subsequently hydrolysed by addition of water (Fig. 3) . It should be mentioned that only this approach allows the introduction of different ester moieties in the carboxylate and the phosphonate residue of the phosphonoformate structure. The PFA di-and triester derivatives 3-10 were subsequently purified by chromatography, and it is noteworthy that one should add some acetic acid to the eluent during the chromatography of the PFA triesters 4-6, 9 and 10 in order to avoid decomposition on silica gel. This already points to the hydrolytic instability of these compounds. All title compounds were characterized by IH, 13C and 31 p NMR spectroscopy, and by electrospray (ESI; negative mode) mass spectrometry (Rozenski et al., 1997) .
All compounds were evaluated for their inhibition of HIV in CEM-SS, CEM-TIC (HIV-1 LA1 ) and MT-4 (HIV-1 rrm) cells as well as ofHBY. PFA 1 and AZT 2 were included as reference compounds. The anti-HIV data are summarized in Table 1 .
Discussion
PFA alkyl triesters 4-6 and PFA (1) itself were inactive against HIV at non-toxic concentrations (Table 1) , whereas the diester 3 showed a slight increase in activity as compared to PFA. In contrast, none of the PFA-AZT conjugates 7-10 possessed antiviral activity in CEM-SS or tEC so , 50% effective concentration or concentration required to inhibit the replication of HIV-1 by 50%.
:):CC so , 50% cytotoxic concentration or concentration required to reduce the viability of uninfected cells by 50%.
MT-4 cells. AZT as reference showed EC so values similar to those of n-octyl-di-AZT-PFA triester 9 and z-buryl-SATE-di-AZT-PFA triester 10 in CEM-SS and MT-4 cells. In contrast, n-octyl-AZT-PFA diester 7 and z-butyl-SATE-AZT-PFA diester 8 exhibited activities that were 1-3 loglO lower compared to AZT. The results summarized in Table 1 show clearly that the high lipophilicity of the noctyl as well as the the t-butyl-SATE groups seems to be insufficient to compensate the polarity of the remaining negatively charged phosphonate moiety. The reason why the n-octyl-AZT-PFA diester 7 is nearly 100-fold more active than the t-butyl-SATE-AZT-PFA diester 8 remains uncertain. This result contrasts with our initial aim. We speculated that a bioreversible ester protecting group like the SATE group would be easily cleaved by cellular enzymes, but obviously the SATE group has no advantage as compared to the n-octyl residue. It is possible that the charged SATE-phosphonoformate diester 7 is not a substrate for the target esterase enzymes. Studies concerning that possibility are currently underway. It is interesting to note that anti-HIV activity was lost in the CEM-TK-cell assay in the case of the PFA-AZT conjugates 7, 9 and 10 and greatly reduced in the case of 8. The higher activity in the wild-type cell lines seems to be due to an unselective delivery of AZT under the assay conditions. Additionally, no synergistic effect of AZT and PFA could be observed. Consequently, the derivatives synthesized here do not improve the bioavailability of PFA nor they act as pronucleotides of AZT-monophosphate. At least they are prodrug forms of AZT. On the other hand, this fact alone could be important with respect to the toxicity and detoxification mechanisms of AZT. When tested against HEV replication in 2.2.15 cells, PFA, AZT and PFA derivatives 3-10 proved to be completely inactive (data not shown).
One plausible reason for the low activity or lack of activity of the lipophilic PFA triesters 4-6, 9 and 10 both Antiviral Chemistry & Chemotherapy 9:1 in anti-HIV and anti-HEY assays is their high instability in aqueous media. The hydrolysis ofPFA triesters involves a nucleophilic attack of water at the carbonyl C atom which results in a cleavage of the C-P bond and consequently to the destruction of the phosphonoformate structure (Krol et aI., 1991 (Krol et aI., , 1993 Mitchell et al., 1991 Mitchell et al., , 1992 . This unselective chemical hydrolysis seems to play the major role in all biological assays reported here. Also, the biolabile (t-butyl-SATE) group is not able to avoid this fast chemical hydrolysis. On the other hand, the ineffectiveness of the PFA diesters could be due to poor membrane penetration caused by the remaining charge at the phosphonate moiety. Additionally, it is possible that no intracellular enzymatic degradation takes place and chemical hydrolysis is too slow. Further studies concerning these topics are under investigation in our laboratories.
Finally, the title compounds 1-10 were also tested for their in vitro inhibitory effects on the replication of three DNA viruses (HCMV, HSV and vaccina virus) and one RNA virus (coxsackie virus E4) in human embryonic fibroblasts (cell line MRC-5). None of the compounds showed marked antiviral effects or detectable alteration of host cell morphology at the highest concentration tested (generally 100~lM), except the PFA alkyl triesters 4 and 5, which had ED so of50~tM against HCMVinMRC-5 cells without toxicity at this concentration, and the trisfzbutyISATE)PFA derivative 6 which had the same ED so and CC so (50~lM), also against HCMV in MRC-5 cells (data not shown).
From the present work, it is obvious that none of synthesized PFA prodrugs 4-6 and PFA-AZT conjugates 7-10 surpassed PFA or AZT in an in vitro antiviral activity. Only the bis (t-butyl-SATE) diester 3 showed better anti-HIV activity than PFA. We postulate that the anti-HIV activity of the PFA-AZT conjugates 7-10 observed in CEM-SS and MT-4 cells is due to the release of the parent nucleosides AZT, which explains why compounds 7-10 have no activity in a thymidine kinasedeficient cell line. Furthermore, it seems improbable that a synergistic effect between PFA and AZT could occur, since the anti-HIV potency of AZT is very much higher than that of PFA. So, even if released from conjugates 7-10, PFA at the same dose as AZT would not contribute to the anti-HIV effects observed. Clearly, based on the present work and on related previously reported results, more detailed studies are necessary in order to prove the suitability of PFA prodrugs and conjugates in antiviral chemotherapy.
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